505 related articles for article (PubMed ID: 11431729)
21. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
[TBL] [Abstract][Full Text] [Related]
22. Renal vasoconstriction induced by oxidized LDL is inhibited by scavengers of reactive oxygen species and L-arginine.
Rahman MM; Varghese Z; Fuller BJ; Moorhead JF
Clin Nephrol; 1999 Feb; 51(2):98-107. PubMed ID: 10069645
[TBL] [Abstract][Full Text] [Related]
23. Effect of nitric oxide inhibition on blood pressure and renal sodium handling: a dose-response study in healthy man.
Larsen T; Mose FH; Bech JN; Pedersen EB
Clin Exp Hypertens; 2012; 34(8):567-74. PubMed ID: 22559218
[TBL] [Abstract][Full Text] [Related]
24. Haemodynamic (systemic and renal) and humoral interactions between nicardipine and domperidone in hypertensives.
Lucarini AR; Salvetti A
J Hypertens Suppl; 1987 Dec; 5(5):S571-4. PubMed ID: 3327930
[TBL] [Abstract][Full Text] [Related]
25. [Dexamethasone, an inhibitor of the expression of inducible nitric oxide synthase, does not modify the hyperdynamic state in cirrhotic rats].
Albornoz L; Bandi JC; de las Heras M; Mastai R
Medicina (B Aires); 2000; 60(4):477-81. PubMed ID: 11188955
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
Genesca J; Gonzalez A; Segura R; Catalan R; Marti R; Varela E; Cadelina G; Martinez M; Lopez-Talavera JC; Esteban R; Groszmann RJ; Guardia J
Am J Gastroenterol; 1999 Jan; 94(1):169-77. PubMed ID: 9934750
[TBL] [Abstract][Full Text] [Related]
27. Physiological role of nitric oxide in regulation of renal function in humans.
Haynes WG; Hand MF; Dockrell ME; Eadington DW; Lee MR; Hussein Z; Benjamin N; Webb DJ
Am J Physiol; 1997 Mar; 272(3 Pt 2):F364-71. PubMed ID: 9087680
[TBL] [Abstract][Full Text] [Related]
28. Subpressor dose asymmetric dimethylarginine modulates renal function in humans through nitric oxide synthase inhibition.
Kielstein JT; Simmel S; Bode-Böger SM; Roth HJ; Schmidt-Gayk H; Haller H; Fliser D
Kidney Blood Press Res; 2004; 27(3):143-7. PubMed ID: 15192321
[TBL] [Abstract][Full Text] [Related]
29. The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.
Kalambokis G; Economou M; Fotopoulos A; Al Bokharhii J; Pappas C; Katsaraki A; Tsianos EV
Am J Gastroenterol; 2005 Apr; 100(4):879-85. PubMed ID: 15784036
[TBL] [Abstract][Full Text] [Related]
30. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
[TBL] [Abstract][Full Text] [Related]
31. Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
Coll M; Rodriguez S; Raurell I; Ezkurdia N; Brull A; Augustin S; Guardia J; Esteban R; Martell M; Genescà J
Hepatology; 2012 Nov; 56(5):1849-60. PubMed ID: 22610782
[TBL] [Abstract][Full Text] [Related]
32. Rapid non-genomic effects of aldosterone on the renal vasculature.
Schmidt BM
Steroids; 2008 Oct; 73(9-10):961-5. PubMed ID: 18242654
[TBL] [Abstract][Full Text] [Related]
33. The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in men.
Schmidt A; Bayerle-Eder M; Pleiner H; Zeisner C; Wolzt M; Mayer G; Schmetterer L
Nitric Oxide; 2001 Aug; 5(4):370-6. PubMed ID: 11485375
[TBL] [Abstract][Full Text] [Related]
34. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
[TBL] [Abstract][Full Text] [Related]
35. Effects of a nitric oxide synthesis inhibitor on renal sodium handling and diluting capacity in humans.
Dijkhorst-Oei LT; Koomans HA
Nephrol Dial Transplant; 1998 Mar; 13(3):587-93. PubMed ID: 9550632
[TBL] [Abstract][Full Text] [Related]
36. Effect of nebivolol, a novel beta 1-selective adrenoceptor antagonist with vasodilating properties, on kidney function.
Greven J; Gabriëls G
Arzneimittelforschung; 2000 Nov; 50(11):973-9. PubMed ID: 11148863
[TBL] [Abstract][Full Text] [Related]
37. Partial blockade of nitric oxide synthase blunts the exercise-induced increase of von Willebrand factor antigen and of factor VIII in man.
Jilma B; Dirnberger E; Eichler HG; Matulla B; Schmetterer L; Kapiotis S; Speiser W; Wagner OF
Thromb Haemost; 1997 Oct; 78(4):1268-71. PubMed ID: 9364996
[TBL] [Abstract][Full Text] [Related]
38. Effects of cerivastatin on forearm vascular responses, blood pressure responsiveness and ambulatory blood pressure in type 2 diabetic men.
Tran D; Lowy A; Howes JB; Howes LG
Diabetes Obes Metab; 2005 May; 7(3):273-81. PubMed ID: 15811145
[TBL] [Abstract][Full Text] [Related]
39. Basal nitric oxide synthase activity is a major determinant of glomerular haemodynamics in humans.
Schlaich MP; Schmitt D; Ott C; Schmidt BM; Schmieder RE
J Hypertens; 2008 Jan; 26(1):110-6. PubMed ID: 18090547
[TBL] [Abstract][Full Text] [Related]
40. Exaggerated natriuresis during clamping of systemic NO supply in healthy young men.
Simonsen JA; Rasmussen MS; Vach W; Høilund-Carlsen PF; Bie P
Clin Sci (Lond); 2012 Jan; 122(2):63-73. PubMed ID: 21749320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
